TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04515407

Intervention type: OTHER
Group type: OTHER
Intervention: PAS at Rest
Description: Paired Associative Stimulation will be delivered while the participant is seated and resting.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS at Rest
Description: Paired Associative Stimulation will be delivered while the participant is seated and resting.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS at Rest
Description: Paired Associative Stimulation will be delivered while the participant is seated and resting.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Active
Description: Paired Associative Stimulation will be delivered while the participant is seated and producing submaximal background activity in the plantarflexor muscles.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Active
Description: Paired Associative Stimulation will be delivered while the participant is seated and producing submaximal background activity in the plantarflexor muscles.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Active
Description: Paired Associative Stimulation will be delivered while the participant is seated and producing submaximal background activity in the plantarflexor muscles.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Walking
Description: Paired Associative Stimulation will be delivered while the participant is walking, during the late stance phase of the gait cycle.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Walking
Description: Paired Associative Stimulation will be delivered while the participant is walking, during the late stance phase of the gait cycle.

Intervention type: OTHER
Group type: OTHER
Intervention: PAS - Walking
Description: Paired Associative Stimulation will be delivered while the participant is walking, during the late stance phase of the gait cycle.
Study: NCT04945447

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systematic pharmacist intervention
Description: Already described in the arm group intervention group for patient level

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systematic pharmacist intervention
Description: Already described in the arm group intervention group for patient level
Study: NCT04556409

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low intensity pulsed ultrasound plus static abdominal and pelvic floor exercises.
Description: Ultrasonic irradiation was employed with parameters of current use in clinical practice, including lower potency (0.16 W/cm2), which is more adequate for stimulation of nerve regeneration, according to results obtained in investigations in which the irradiation was applied at the lesion site 32, 33.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low level LASER plus static abdominal and pelvic floor exercises.
Description: Application of laser irradiation (Ga-As laser) in the site of the anastomosis inhibits the degeneration process, accelerate remyelination, and nerve function recovery 27, 28

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: static abdominal and pelvic floor exercises only.
Description: static abdominal and pelvic floor exercises., 3 times/week for 4 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: static abdominal and pelvic floor exercises only.
Description: static abdominal and pelvic floor exercises., 3 times/week for 4 weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: static abdominal and pelvic floor exercises only.
Description: static abdominal and pelvic floor exercises., 3 times/week for 4 weeks.
Study: NCT06118242

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of oral care solutions
Description: Oral care solutions to be used: Chlorhexidine Gluconate, Sodium Bicarbonate, Ozonated Water and Hypochlorous Acid

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of oral care solutions
Description: Oral care solutions to be used: Chlorhexidine Gluconate, Sodium Bicarbonate, Ozonated Water and Hypochlorous Acid
Study: NCT05383638

Intervention type: OTHER
Group type: OTHER
Intervention: Health education
Description: Intervention is achieved through health education. Analyze the factors that may affect patients' satisfaction with primary medical services through existing data, and carry out targeted health education.
Study: NCT04698746

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular nerve group block
Description: PENG block will be made with 15 ml 0.5% bupivacaine + 2 mg dexamethasone + 14.5 ml NaCl under US-guidance

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular local anesthetic injection
Description: Intra-articular local anesthetic injection will be made with 10 ml 0.5% bupivacaine + 2 mg dexamethasone + 9.5 ml NaCl
Study: NCT05897047

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Additional interventional telemedical management
Description: Predefined additional telemedical management including regular telemedicine visits and automatic data transfer (e.g. vital signs, well-being, medication plan laboratory data and chat) between the patient at home and KTC through a certified smartphone application.
Study: NCT05879003

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: novel brace with neuromuscular electrical stimulation
Description: The symptomatic rotator cuff tear subjects had NMES on scapular muscles and adductor muscle
Study: NCT06034132

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stock healing abutments
Description: 2ND stage surgery will be performed and stock healing abutment were placed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compoiste healing abutments
Description: 2ND stage surgery will be performed and composite healing abutment were placed
Study: NCT05867225

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic hiatal hernia repair
Description: laparoscopic hiatal hernia repair has replaced the traditional laparotomic or thoracotomic approach, and has resulted in a reduction of length of hospital stay and morbidity, and increased patients' acceptance

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Laparoscopic hiatal hernia repair
Description: laparoscopic hiatal hernia repair has replaced the traditional laparotomic or thoracotomic approach, and has resulted in a reduction of length of hospital stay and morbidity, and increased patients' acceptance
Study: NCT05879003

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: scapular and adductor exercise
Description: The symptomatic rotator cuff tear subjects conduct scapular and adductor exercise
Study: NCT05665426

Intervention type: OTHER
Group type: OTHER
Intervention: acupuncture
Description: Patients allocated to the acupuncture group will be punctured at the pre-specified acupoints. According to the theory of traditional Chinese medicine and clinical experience, we will use the Bilateral Weizhong point (BL 40). Because of the similar anatomy, the Chize point (LU 5) was chosen as a control. Sterile disposable stainless steel acupuncture needles (length: 40 mm, diameter: 0.25 mm; Hwato, Suzhou, China) will be used.
Study: NCT04696393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitapivat tablet
Description: Oral tablets
Study: NCT05161793

Intervention type: DEVICE
Intervention: Tele-Monitor DM
Description: Remote monitoring of CGM data to identify, contact, and provide diabetes management for patients who are having episodes of hypoglycemia, hyperglycemia and/or difficulty using their CGM device.

Intervention type: DEVICE
Intervention: Tele-Monitor DM
Description: Remote monitoring of CGM data to identify, contact, and provide diabetes management for patients who are having episodes of hypoglycemia, hyperglycemia and/or difficulty using their CGM device.
Study: NCT05801445

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupation-based activity
Description: Painting large-scale canvas

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Body-Weight Exercise
Description: Body-weight exercises designed for older adults
Study: NCT04996368

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Randomized comparison of two doses of tranexamic acid as prophylactic before start of incision in open heart surgery use for prevention of bleeding.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Randomized comparison of two doses of tranexamic acid as prophylactic before start of incision in open heart surgery use for prevention of bleeding.
Study: NCT06546540

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept
Description: 160mg，once weekly
Study: NCT05037747

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding(TRF)
Description: The TRF group was asked to restrict the eating window to 8 hours a day, during waking hours and also continue a low-protein diet.
Study: NCT06444490

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Approach Instruction
Description: Oral health instruction focused more broadly on the different topics of oral diseases and oral hygiene care.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalised Technique Instruction
Description: Oral health instruction based on the specific needs of each participant.
Study: NCT05311722

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Inj dexmedetomidine, will be given in infusion over 10 mins and their effect on post spinal shivering will be assessed.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Ketamine
Study: NCT05665426

Intervention type: OTHER
Group type: OTHER
Intervention: moxibustion
Description: Moxibustion Participants in the moxibustion group will receive moxibustion treatment via portable Moxibustion (Aikeshu, Bozhou, China); the moxibustion is composed of The inner tube (containing the moxa pillar) and the outer tube. To use, pull out the inner tube and light the moxa pillar, then insert the outer tube and fix the moxibustion on the acupuncture points. Two Moxibustion devices will be sequentially applied at two acupoints Weizhong (BL 40) and Chize (LU 5), for 30 minutes.
Study: NCT05311722

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Tramadol
Study: NCT06292390

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pet Therapy
Description: Pet therapy was applied to the individuals in the intervention group for 6 weeks in addition to their normal routine lives. This therapy was applied every 20 minutes, 2 days a week. Repeated measurements were made before therapy, at the end of therapy and 4 weeks after the end of therapy.
Study: NCT04840342

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eplerenone
Description: Dose escalations of eplerenone 50, 100, or 200mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine
Description: Dose escalations of amlodipine 2.5, 5, or 10mg
Study: NCT05176366

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ExoFlo
Description: Intravenous administration of bone marrow mesenchymal stem cell derived extracellular vesicles
Study: NCT05828758

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: Amoxicillin 10 mg/kg (50 mg/ml concentration) by nasogastric tube 3 times daily (8 hours apart) 10 minutes before bolus gastric feeding for 7 days.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Distilled water 0.2 ml/kg by nasogastric tube 3 times daily (8 hours apart) 10 minutes before bolus gastric feeding for 7 days.
Study: NCT05306249

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD LGP 50
Description: Patients will receive CBD LGP 50 at a dose of 1 mg/kg twice a day in the form of oil dispensed through a graduated pipette until the end of week 12.
Study: NCT05964439

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HoloUS app for ultrasound visualization
Description: Study participants will wear HoloLens see-through glasses and use the HoloUS app for ultrasound visualization in the conduct of a vascular access procedure in a phantom.
Study: NCT04235816

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin
Description: Administration of azithromycin during the first 15 months of life through the Expanded Program on Immunisation

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of placebo during the first 15 months of life through the Expanded Program on Immunisation
Study: NCT06262022

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cold therapy
Description: A cold ice pack will be applied to the patient's knee for 20 minutes every hour for three days, starting after total knee arthroplasty.
Study: NCT06427629

Intervention type: DEVICE
Group type: OTHER
Intervention: Imaging of conjunctival goblet cell
Description: After instillation of moxifloxacin and illuminating with a 405nm light source using confocal fluorescence microscopy, conjunctival goblet cell imaging will be performed in patients with ocular surface disease and patients scheduled for ocular surgery without ocular surface disease

Intervention type: DEVICE
Group type: OTHER
Intervention: Imaging of conjunctival goblet cell
Description: After instillation of moxifloxacin and illuminating with a 405nm light source using confocal fluorescence microscopy, conjunctival goblet cell imaging will be performed in patients with ocular surface disease and patients scheduled for ocular surgery without ocular surface disease
Study: NCT05306249

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive the MCT oil placebo without CBD until the end of week 12.
Study: NCT04561986

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tocilizumab
Description: Tocilizumab is a recombinant humanized monoclonal antibody directed against the human interleukin-6 (IL-6) receptor
Study: NCT04940364

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemdisiran
Description: Administered SC per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemdisiran
Description: Administered SC per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemdisiran
Description: Administered SC per protocol
Study: NCT05172492

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endocare
Description: Endocare will be administred through a virtual reality headseat used one to twice a day.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Digital control
Description: Digital control will be administred through a virtual reality headseat used one to twice a day.
Study: NCT05287347

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Specimen
Description: Blood samples will be collected from study participants at one time-point in the study, for the following:~1. tumor markers CEA and CA 19-9: 2 ml blood will be collected.~2. glycomics: 0.5 cc blood will be collected~3. ctDNA: 20 cc blood will be collected
Study: NCT05921669

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provide breastfeeding education
Description: Providing breastfeeding education within the first 24 hours after birth

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provide breastfeeding education
Description: Providing breastfeeding education within the first 24 hours after birth
Study: NCT05739136

Intervention type: DRUG
Intervention: Relugolix + Estradiol + Norethindrone Acetate
Description: Relugolix combination therapy (relugolix 40 mg; estradiol 1 mg; norethindrone 0.5 mg)
Study: NCT06138717

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: yoga based exercises
Description: Aerobic exercises will be performed with a lower extremity ergometer for 30 minutes and 12 sessions.In group 2, in addition to aerobic exercises, spinal stretching, relaxation, respiration and meditation will be performed. A yoga-based exercise programme consisting of exercises will be applied for 40 minutes and 12 session

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: yoga based exercises
Description: Aerobic exercises will be performed with a lower extremity ergometer for 30 minutes and 12 sessions.In group 2, in addition to aerobic exercises, spinal stretching, relaxation, respiration and meditation will be performed. A yoga-based exercise programme consisting of exercises will be applied for 40 minutes and 12 session
Study: NCT05572892

Intervention type: OTHER
Intervention: FAC scale
Description: Measurement of walking dependency according to the FAC scale :~* in the first week after stroke (in neurology by physiotherapists),~* then at 6 weeks, 12 weeks and 6 months (by telephone).~Trunk Control Test score (in the first week after stroke, by physiotherapists).~MRC score of hip extension and hip flexion, knee flexion/extension, ankle plantar and dorsal flexion (in the first week after stroke, by physiotherapists).~PHQ-9 depression scale (at 6 weeks by phone).~Denutrition (weight loss between neurology weight and 6-week weight, BMI +/- albumin).~Other intercurrent medical problems (at each telephone interview).
Study: NCT06033170

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CELOX™ PPH
Description: Celox™ PPH is intended to be a physical haemostatic treatment for control and treatment of uterine postpartum hemorrhage (PPH) when conservative management is warranted.
Study: NCT05253859

Intervention type: OTHER
Intervention: No intervention
Description: Registry study: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: Registry study: No intervention
Study: NCT05625932

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinzaparin
Description: Patients \< 80 kg will receive a fixed dose of 4500 IU daily. Patients between 80-100 kg will receive a fixed dose of 6000 IU daily. Patients \> 100 kg will receive a fixed dose of 8000 IU daily.
Study: NCT04312932

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCPUFA Oil Supplement
Description: 25 mg/kg, 50 mg/kg, or 75 mg/kg of GLA+EPA+DHA as Omega 3-6 oil to be administered twice per day by mouth for 90 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Canola Oil Placebo
Description: Equal volume (25 mg/kg, 50 mg/kg, or 75 mg/kg) of placebo (canola) oil to be administered twice per day by mouth for 90 days
Study: NCT05952947

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HRYZ-T101 Injection
Description: On day 1, the TCR-T cells will be administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine + Cyclophosphamide
Description: Fludarabine: 25mg/m²/day×3days; Cyclophosphamide: 250mg/m²/day×3 days
Study: NCT05344677

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trendelenburg Position
Description: Group 1 (trendlenburg position group) in which the women will be positioned in a Trendelenburg position (20 °) once fully awake and cooperative in the recovery room and will remain in this posture for the first 24 hrs postoperatively. The maximum time allowed in a straight-up position will be three 15-min intervals over a 24-h period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warm Pad Application
Description: • Group 2 (warm pad application group) in this group warm pad (38◦C -40◦C) will be applied on the shoulder after four hours postoperatively for a period of 5-10 minutes. Each woman will be asked to place heat pads when needed during the first 24 hours.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deep Breathing Exercise
Description: • Group 3: (deep breathing group) the researcher will instruct women after the end of surgery and upon consciousness to take slowly deep breathing while observing her chest and hold her breath for about 5 seconds and then exhale slowly, repeating this deep breathing technique five times after full vigilance within the first 3 hours after surgery. Then, the process will be repeated 6, 12, and 24 h later. The patient will be instructed about this type of breathing before surgery by researchers.
Study: NCT05893589

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: test group
Description: Women in the intervention group participated in face-to-face and virtual meetings based on social cognitive theory structures for 4 weeks
Study: NCT06485570

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: creative drama training
Description: The trainings prepared by the researcher in line with the literature information on Environmental Theory, Self-Care Disability Theory and Adaptation Model will be carried out in 3 sessions with creative drama teaching method to the experimental group. The trainings will be planned in the classroom environment for 4 weeks and 2 lesson hours (100 minutes) for each session. At the end of the trainings, Knowledge Measurement Questionnaire and Perception of Nursing Profession Scale will be applied to the participants as a post-test to measure their level of knowledge about nursing theories. In the third stage of the study, semi-structured interviews will be conducted with the students from the experimental group after the applications in order to reveal the participants' views on teaching methods.

Intervention type: OTHER
Group type: OTHER
Intervention: control
Description: control group
Study: NCT05992688

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sucrose sweetened beverage
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stevia sweetened beverages
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calorie free flavored water beverage
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.
Study: NCT06291129

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Periodontal therapy
Description: Supragingival scaling sessions were performed with ultrasonic scalers (Dabi Atlante, Rio de Janeiro, RJ, Brazil) to remove all calculus and biofilms, in addition to oral hygiene guidelines, including brushing technique and interdental cleaning with dental floss.